1. Home
  2. ANNX vs PMT Comparison

ANNX vs PMT Comparison

Compare ANNX & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Annexon Inc.

ANNX

Annexon Inc.

N/A

Current Price

$4.28

Market Cap

726.1M

Sector

Health Care

ML Signal

N/A

Logo PennyMac Mortgage Investment Trust of Beneficial Interest

PMT

PennyMac Mortgage Investment Trust of Beneficial Interest

N/A

Current Price

$7.80

Market Cap

812.7M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
ANNX
PMT
Founded
2011
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
726.1M
812.7M
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
ANNX
PMT
Price
$4.28
$7.80
Analyst Decision
Buy
Hold
Analyst Count
10
8
Target Price
★ $17.00
$9.75
AVG Volume (30 Days)
★ 3.6M
2.9M
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
★ 20.33%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $351,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$28.15
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.54
$6.70
52 Week High
$7.18
$13.80

Technical Indicators

Market Signals
Indicator
ANNX
PMT
Relative Strength Index (RSI) 56.67 51.47
Support Level $3.71 $6.70
Resistance Level $4.37 $9.80
Average True Range (ATR) 0.26 0.27
MACD 0.06 0.13
Stochastic Oscillator 73.86 58.88

Price Performance

Historical Comparison
ANNX
PMT

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

Share on Social Networks: